Seeking Alpha

PGNX
  Progenics Pharmaceuticals Inc. - NASDAQ

10/24/2014, 12:55 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
PGNX vs. ETF Alternatives
Company Description
Progenics Pharmaceuticals Inc is engaged in the development of medicines for oncology .It develops products for the treatment of prostate cancer, for the treatment of opioid-induced constipation, or OIC, as well as OIC for non-cancer pain.
Sector: Healthcare
Industry: Biotechnology
Country: United States